Nonalcoholic fatty liver disease: an agenda for clinical research.
about
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitisAntioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisBile acids for non-alcoholic fatty liver disease and/or steatohepatitisCurrent status of intragastric balloon for obesity treatmentToll-like receptors in pathophysiology of liver diseasesSirtuins and nonalcoholic fatty liver diseaseAssociation between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance.Hypertension and fatty liver: guilty by association?Investigational pharmacologic treatment for liver disease.Non-alcoholic fatty liver disease: an overview.Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistanceObesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.Hepatic steatosis in obese patients: clinical aspects and prognostic significance.Gut microbiota and inflammation.High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?Nonalcoholic fatty liver disease: is all the fat bad?Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis.Microarray technology in the study of obesity and non-alcoholic fatty liver disease.Histological assessment of non-alcoholic fatty liver disease.Bariatric surgery for pediatric extreme obesity: now or later?Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease and the metabolic syndrome: an update.A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).Nonalcoholic fatty liver disease: from clinical recognition to treatment.Does physical inactivity cause nonalcoholic fatty liver disease?Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.Role of the diet as a link between oxidative stress and liver diseasesProposal for a histological scoring and grading system for non-alcoholic fatty liver disease.Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats.The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan.A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy.A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity.Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease.Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.Role of NKT Cells in the Pathogenesis of NAFLD.The role of liver biopsy in detection of hepatic oxidative stress.A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease
P2860
Q24243033-356F7440-552D-4B90-9792-EC20B2920FD8Q24243125-2E77C9C7-05C8-4D4C-AAC7-402CBD801E37Q24243149-A1BF30B4-D0D5-44F2-8DB9-AF0803817D95Q26746920-D844C7C2-AF30-477F-8E75-0F02B23A02D8Q28070077-7D52C858-F02A-4A95-9661-9250E002F755Q28079953-10B9D097-823C-4418-9833-F2F3B525AA43Q33347569-C66861A7-3082-40D5-BD66-D50671AE2C44Q33642230-B53189A6-1C83-4777-8EC1-5132581114FCQ34608817-4F04441D-0D56-450A-AF30-D4AF98182B48Q34841865-F45D5654-DFA3-4E90-BB81-D9CC037D197CQ35009628-E508AD46-93C0-4EA9-B7A9-D9AE5B4463E5Q35596637-C90F295D-58FC-460F-B095-02AEA2151FBEQ35603803-968FF217-06DF-4DFA-916D-AAFA573840C1Q35669794-3D529F47-5B40-4E66-A4E2-ECDF2DB82E32Q35670894-5E374CA2-2796-4EE7-89C8-763FC5D67DBCQ35683422-B5A7270C-5DDB-45AE-BEC1-A23135ECDE89Q35687669-280193ED-52C3-4FFE-89C4-AF8D5557CF6FQ35746690-7077E6E7-8A06-4A70-9E2E-55499B5AAEA2Q35916987-AF6DDC51-109F-4C6A-93B4-835C6E8EF779Q36338671-E9669B55-0DB2-4778-B8A3-66EB7B23929EQ36634377-DB41BC46-1C2C-4AB5-83BD-9D15A5346BCEQ36685885-C10CC147-6146-4261-BB90-DD808212F70AQ36748514-58325CA3-A1BF-4ECD-A2D6-35A59F27064EQ37054351-58A27C78-17F5-4B79-A387-C9EB9B410F09Q37278117-1156D390-EAD1-48A6-9F5F-93AC36E1A1EEQ37345907-99809146-E3DC-475D-8D7E-2429CBA03DB2Q37874856-21AFDD75-C810-4508-A6FC-07CF949F7DC2Q37886792-D8814186-386A-4A42-8DA9-67477E4261B7Q38320278-579E0153-0EDD-4F58-A3A5-E7634F513CEBQ38416523-E4D62312-24E2-4125-9A3E-B499C75F3C05Q38610764-C001116C-2BA7-4CE3-B828-B3225A07BF9CQ39106340-26A36336-F9C9-4D83-958F-D4F5DE2421C2Q40728791-02B227E3-3CE8-459A-AB8E-70FF564B5F9EQ40937669-F8661B21-F6B9-4176-9115-BEC63C2C939DQ40958800-CDC0AD2F-385E-47D1-9036-62B91D7E22B7Q40959440-08B2561C-8573-4BAA-B2B1-5291A2D4B132Q41546112-60B36B2D-8574-4B33-9A27-5E094137404DQ41873565-DA123D72-3F51-4981-A3BD-8558D8A62891Q42001692-CC2BE5F9-99F1-412D-A3C2-E1D5982D8040Q42109041-BC585C46-667B-4E73-BDD8-75EAEC2E2420
P2860
Nonalcoholic fatty liver disease: an agenda for clinical research.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nonalcoholic fatty liver disease: an agenda for clinical research.
@ast
Nonalcoholic fatty liver disease: an agenda for clinical research.
@en
Nonalcoholic fatty liver disease: an agenda for clinical research.
@nl
type
label
Nonalcoholic fatty liver disease: an agenda for clinical research.
@ast
Nonalcoholic fatty liver disease: an agenda for clinical research.
@en
Nonalcoholic fatty liver disease: an agenda for clinical research.
@nl
prefLabel
Nonalcoholic fatty liver disease: an agenda for clinical research.
@ast
Nonalcoholic fatty liver disease: an agenda for clinical research.
@en
Nonalcoholic fatty liver disease: an agenda for clinical research.
@nl
P2093
P356
P1433
P1476
Nonalcoholic fatty liver disease: an agenda for clinical research.
@en
P2093
Anna Mae Diehl
Janus P Ong
Zobair M Younossi
P304
P356
10.1053/JHEP.2002.32483
P407
P577
2002-04-01T00:00:00Z